Subject
Industrial and Manufacturing Engineering,Polymers and Plastics,Business and International Management
Reference24 articles.
1. Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial;Khanna;Lancet Respir Med,2020
2. Long-term safety and efficacy of tocilizumab in early systemic sclerosis–interstitial lung disease: open-label extension of a phase 3 randomized controlled trial;Khanna;Am J Respir Crit Care Med,2022
3. Safety and efficacy of rituximab in systemic sclerosis (DESIRES): a double-blind, investigator-initiated, randomised, placebo-controlled trial;Ebata;Lancet Rheumatol,2021
4. Predictors of rituximab effect on modified Rodnan skin score in systemic sclerosis: a machine learning analysis of the DESIRES trial;Ebata;Rheumatology (Oxford),2022
5. JAK1/2 inhibitor baricitinib improves skin fibrosis and digital ulcers in systemic sclerosis;Hou;Front Med,2022